Сomparative characteristics of cytokine profile induced in vitro by supernatants of industrial and intestinal strains of bifido- and lactobacteria

The immunomodulatory properties of probiotics largely depend on the metabolites secreted into the culture medium, which is studied as a cell-free supernatant and referred to as postbiotics. The aim of the present work was to conduct screening of cytokine profiles for intestinal strains of Bifidobacteria and Lactobacillus by testing it with mononuclear cells from human peripheral blood, and comparing it with cytokine profile of typical industrial bacterial strains, in order to select promising strains with anti-inflammatory properties as potential pro-/postbiotics. The cytokine profile of probiotic and intestinal strains of Bifidobacteria and Lactobacillus isolated from the large intestine of healthy people was determined by the biological effects of cell-free supernatants on the production of pro- (IFNγ, TNFα, IL-17, IL-8, IL-6) and anti-inflammatory (IL-10, IL-1ra) cytokines in the in vitro model of peripheral mononuclear cells isolated from human blood. We have established three types of effects on the cytokine profile: type 1 was characterized by a predominant increase in IL-10 production, and a decrease in TNFα, IL-17, IL-6; type 2, produced a decrease, mainly at the level of pro-inflammatory cytokines; type 3 caused a decreased secretion of both pro- and anti-inflammatory cytokines. Among type 1 and type 2 cultures, the Bifidobacterium bifidum ICIS-202 and Bifidobacterium bifidum ICIS-504 strains had high anti-inflammatory potential, capable of both suppressing the secretion of pro-inflammatory cytokines, and enhancing the production of anti-inflammatory cytokines. The supernatant of L. ruminis ICIS-540 strain showed a promising effect, i.e., it repeatedly reduced the level of early proinflammatory TNFα cytokine. The anti-inflammatory activity of these strains was not inferior, but, in relation to individual cytokines (IL-10, TNFα, IL-6), was superior to the known probiotic bacterial cultures. The in vitro testing of metabolic products in bacterial supernatants enabled us to select promising strains of L. ruminis ICIS-540, B. bifidum ICIS-504 and B. bifidum ICIS-202 which may be suitable for implementation of bacterial preparations with anti-inflammatory activity.

1. Al-Najjar M.A.A., Abdulrazzaq S.B., Alzaghari L.F., Mahmod A.I., Omar A., Hasen E., Athamneh T., Talib W.H., Chellappan D.K., Barakat M. Evaluation of immunomodulatory potential of probiotic conditioned medium on murine macrophages. Sci Rep., 2024, Vol. 14, 7126. doi: 10.1038/s41598-024-56622-0.

2. Asif A., Afzaal M., Shahid H., Saeed F., Ahmed A., Shah Y.A., Ejaz A., Ghani S., Ateeq H., Khan M.R. Probing the functional and therapeutic properties of postbiotics in relation to their industrial application. Food Sci. Nutr., 2023, Vol. 11, no. 8, pp. 4472-4484.

3. Bermudez-Brito M., Muñoz-Quezada S., Gomez-Llorente C., Romero F., Gil A. Lactobacillus rhamnosus and its cell-free culture supernatant differentially modulate inflammatory biomarkers in Escherichia coli-challenged human dendritic cells. Br. J. Nutr., 2014, Vol. 111, no. 10, pp. 1727-1737.

4. Chen Y.C., Wu Y.J., Hu C.Y. Monosaccharide composition influence and immunomodulatory effects of probiotic exopolysaccharides. Int. J. Biol. Macromol., 2019, Vol. 133, pp. 575-582.

5. oey A., Habil N., Strachan A., Beal J. Lacticaseibacillus casei strain shirota modulates macrophage-intestinal epithelial cell co-culture barrier integrity, bacterial sensing and inflammatory cytokines. Microorganisms, 2022, Vol. 10, no. 10, 2087. doi: 10.3390/microorganisms10102087.

6. Hamad G.M., Abdelmotilib N.M., Darwish A.M., Zeitoun A.M. Commercial probiotic cell-free supernatants for inhibition of Clostridium perfringens poultry meat infection in Egypt. Anaerobe, 2020, Vol. 62, 102181. doi: 10.1016/j.anaerobe.2020.102181.

7. Lee J., Kim S., Kang C.H. Immunostimulatory activity of lactic acid bacteria cell-free supernatants through the activation of NF-κB and MAPK signaling pathways in RAW 264.7 cells. Microorganisms, 2022, Vol. 10, no. 11, 2247. doi: 10.3390/microorganisms10112247.

8. Leser T., Baker A. Molecular mechanisms of Lacticaseibacillus rhamnosus, LGG® probiotic function. Microorganisms, 2024, Vol. 12, no. 4, 794. doi: 10.3390/microorganisms12040794.

9. Liang B., Xing D. The current and future perspectives of postbiotics. Probiotics Antimicrob. Proteins, 2023, Vol. 15, no. 6, pp. 1626-1643.

10. Maghsood F., Mirshafiey A., Farahani M.M., Modarressi M.H., Jafari P., Motevaseli E. Dual effects of cell free supernatants from lactobacillus acidophilus and lactobacillus rhamnosus GG in regulation of MMP-9 by upregulating TIMP-1 and down-regulating CD147 in PMADifferentiated THP-1 cells. Cell J., 2018, Vol. 19, no. 4, pp. 559-568.

11. Magryś A., Pawlik M. Postbiotic fractions of probiotics Lactobacillus plantarum 299v and Lactobacillus rhamnosus GG show immune-modulating effects. Cells, 2023, Vol. 12, no. 21, 2538. doi: 10.3390/cells12212538.

12. Mazziotta C., Tognon M., Martini F., Torreggiani E., Rotondo J.C. Probiotics mechanism of action on immune cells and beneficial effects on human health. Cells, 2023, Vol. 12, no. 1, 184. doi: 10.3390/cells12010184.

13. Prajapati N., Patel J., Singh S., Yadav V.K., Joshi C., Patani A., Prajapati D., Sahoo D.K., Patel A. Postbiotic production: harnessing the power of microbial metabolites for health applications. Front. Microbiol., 2023, Vol. 14, 1306192. doi: 10.3389/fmicb.2023.1306192.

14. Zanetta P., Ballacchino C., Squarzanti D.F., Amoruso A., Pane M., Azzimonti B. Lactobacillus johnsonii LJO02 (DSM 33828) cell-free supernatant and vitamin D improve wound healing and reduce interleukin-6 production in staphylococcus aureus-infected human keratinocytes. Pharmaceutics, 2023, Vol. 16, no. 1, 18. doi: 10.3390/pharmaceutics16010018.

15. Zhang J., Xiao Y., Wang H., Zhang H., Chen W., Lu W. Lactic acid bacteria-derived exopolysaccharide: Formation, immunomodulatory ability, health effects, and structure-function relationship. Microbiol. Res., 2023, Vol. 274, 127432. doi: 10.1016/j.micres.2023.127432.